Clinical association between pre-treatment levels of plasma fibrinogen and bone metastatic burden in newly diagnosed prostate cancer patients

Gansheng Xie, Gang Li, Li Yu, Jinxian Pu, Yuhua Huang, Jinhu Li, Huming YinChinese 2019 · DOI

Abstract

Pre-treatment plasma fibrinogen is positively associated with bone metastatic burden in PCa patients. Our results indicate that fibrinogen might be a potential predictor of HVD.
BibTeX
@inproceedings{xie2019clinical,
  author = {Gansheng Xie and Gang Li and Li Yu and Jinxian Pu and Yuhua Huang and Jinhu Li and Huming Yin},
  title = {{Clinical association between pre-treatment levels of plasma fibrinogen and bone metastatic burden in newly diagnosed prostate cancer patients}},
  booktitle = {Chinese},
  year = {2019},
  doi = {10.1097/cm9.0000000000000506},
}

Loading related content...

Figure